Erlonat 150 Tablet is an anti-cancer medication. Epidermal growth factor receptors (EGFR) are expressed on the lung cancer cell surfaces that modulate their growth. This medicine works by binding the chemical messenger, EGFR, hence, inhibits the cancer signaling pathways mediated by EGFR. This is how it restricts further growth of the cancer cells. Erlonat 150 Tablet is used in the treatment of non-small cell lung cancer and pancreatic cancer. Erlonat 150 Tablet should be taken on an empty stomach or should be taken one hour before or 2 hour after meal.